All News

A new medicine for treating hemophilia B, Rebinyn Coagulation Factor X (recombinant), GlycoPEGlated, has been made available to pharmacies.

Immunotherapy combination outperforms chemotherapy in patients with advanced or metastatic renal cell carcinoma.

Breast cancer survivors are more likely to die from heart disease than cancer.

New diagnosis methods of patients with cardiovascular disease could lead to more personalized treatment.

Officials with the FDA have approved 2 different fixed dose drugs indicated to treat HIV-1: Symfi Lo tablets and Biktarvy.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

New combination therapy gains approval for adult and pediatric patients with HIV-1.

The risk of non-Hodgkin's lymphoma is elevated in patients with hepatitis C virus.

Twenty-two of 25 compounds in kratom bind to mu-opioid receptors.

The fascinating story of an amazing pharmacy in the small town of Corydon, Indiana.

Florida's prescription drug monitoring program (PDMP) was established in 2009 to help combat the controlled substance abuse epidemic plaguing the state.

Direct and indirect remuneration fees remain a top concern for pharmacists in 2018.

Reimbursement changes leave Arkansas pharmacies in jeopardy.

The mechanisms of blood vessel damage from diabetes may affect damage to the heart and eyes.

With thousands of FDA-approved medications on the market, it can be difficult for pharmacists to stay up-to-date on drug name pronunciations.

One in 7 patients who have had lung surgery become persistent opioid users, data note.

Immunotherapy combination beneficial for patients with lung cancer with a high tumor mutation burden.

Evaluating medical and pharmacy benefits can provide a better view of a medication's value.

HIV may target CD4+ T cells that have a higher prevalence of a certain protein on their surfaces.

Top news of the day from across the health care landscape.

Scientists may be able to determine how a flu strain will multiply based on its genetic makeup.

Top news of the day from across the health care landscape.

The genetic makeup of influenza may be able to determine how a strain will multiply.

In newly-released scientific analysis and data, the FDA has indicated strong evidence of the presence of compounds in kratom that strongly bind to opioid receptors, according to a statement released by FDA Commissioner Scott Gottlieb, MD.

Chronic HCV infection has been linked to low serum zinc and low metallothioneins expression in liver cells.

Ubrogepant had a more significant reduction of pain and migraine-associated symptoms within 2 hours of the initial dose than placebo.

Using mouse models, direct injection of CpG/anti-OX40 into tumors creates a systemic immune response.

A number of landmark clinical studies in the field of MS have been published, shaping how the disease is treated.